NLRP3 and acute kidney injury: Our results demonstrate that TXNIP inhibition protects the diabetic kidney from I/R injury and diminishes the AKI sensitivity of diabetic kidney tissues by inhibiting oxidative stress and NLRP3 inflammasome activation.